VS
stockvs
Go to ScreenerHub
JNJ

JNJ vs NVO

NVO

In the past 12 months, JNJ returned +47% while NVO lost 34%.

JNJ
JNJ

Johnson & Johnson

$225.33
-0.9%(1M)
Market Cap542.4B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio26.19
ROE26.3%
P/B Ratio6.79
Dividend Yield2.3%
NVO
NVO

Novo Nordisk A/S

$45.58
13.1%(1M)
Market Cap202.5B
Healthcare
Drug Manufacturers - General
DK
P/E Ratio10.67
ROE66.4%
P/B Ratio6.41
Dividend Yield4.0%
Performance Comparison

Historical returns across multiple timeframes

JNJ leads 6/8
JNJ

JNJ

Johnson & Johnson

+46.7%

1Y Return

NVO

NVO

Novo Nordisk A/S

-34.4%

1Y Return

JNJ
JNJ
NVO
NVO

Short Term

1M-6M

NVO
+9.1%

Medium Term

YTD-1Y

JNJ
+27.8%

Long Term

3Y-10Y

JNJ
+60.7%

Valuation

Compare price multiples and valuation ratios

JNJ: 1NVO: 4
MetricJNJNVOWinner
P/E Ratio

Price to earnings ratio

26.1910.67NVO
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

5.633.97NVO
P/B Ratio

Price to book ratio

6.796.41NVO
P/FCF Ratio

Price to free cash flow ratio

30.4841.94JNJ
EV/EBITDA

Enterprise value to EBITDA

17.027.76NVO
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

JNJ: 0NVO: 6
MetricJNJNVOWinner
Gross Margin

Gross profit margin

69.1%81.8%NVO
Operating Margin

Operating profit margin

26.9%45.3%NVO
Net Margin

Net profit margin

21.8%37.2%NVO
ROE

Return on equity

26.3%66.4%NVO
ROA

Return on assets

10.5%21.8%NVO
ROIC

Return on invested capital

13.6%32.2%NVO

Growth

Compare revenue and earnings growth rates

JNJ: 1NVO: 5
MetricJNJNVOWinner
Revenue Growth (YoY)

Year-over-year revenue growth

6.0%6.4%NVO
Revenue Growth (3Y)

3-year revenue CAGR

5.6%20.4%NVO
Revenue Growth (5Y)

5-year revenue CAGR

2.7%19.5%NVO
EPS Growth (YoY)

Year-over-year EPS growth

90.5%1.8%JNJ
EPS Growth (3Y)

3-year EPS CAGR

17.9%23.5%NVO
EPS Growth (5Y)

5-year EPS CAGR

14.9%20.7%NVO

Balance Sheet & Risk

Compare financial stability and debt levels

JNJ: 5NVO: 0
MetricJNJNVOWinner
Debt/Equity

Debt to equity ratio

0.220.72JNJ
Current Ratio

Current assets to current liabilities

1.030.79JNJ
Quick Ratio

Quick assets to current liabilities

0.770.56JNJ
Interest Coverage

EBIT to interest expense

31.9729.15JNJ
Beta

Stock volatility vs market

0.260.35JNJ
Summary
NVO wins 3-1

Valuation

NVO

Profitability

NVO

Growth

NVO

Balance Sheet

JNJ

NVO is more attractively valued. NVO shows stronger profitability. NVO demonstrates better growth. JNJ has a stronger balance sheet.

Take Your Analysis Further

Dive deeper into JNJ and NVO with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/JNJ/vs/NVO" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare JNJ vs NVO on stockvs.app
</a>